Previous 10 | Next 10 |
2024-04-02 12:13:19 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reduced interest rates make it easier for firms to buy other companies. That’s because acquiring firms can borrow the money needed to finance mergers and acquisitions (M&A) deals...
2024-04-02 06:01:11 ET Summary Viking Therapeutics' share price has rapidly increased from recent weight loss drug excitement. The company’s value seems to be derived from its weight loss and NASH/MASH candidates. VK2735, the weight loss candidate, presents a potentiall...
2024-04-02 05:50:00 ET There aren't many hotter stocks on the market right now than Viking Therapeutics (NASDAQ: VKTX) . Shares of the biopharmaceutical company have skyrocketed around 340% so far this year. However, those impressive gains might be just a start for Viking. The c...
2024-04-01 13:49:00 ET Investors looking for stocks that can make dramatic gains in a short time frame might want to turn their attention to the biopharmaceutical industry. Shares of Viking Therapeutics (NASDAQ: VKTX) have already risen more than four-fold this year. Despite Vik...
2024-03-31 10:47:12 ET Summary Eli Lilly's stock has surged in the first quarter of 2024 due to the success of its weight loss products in the pharma market. A huge rally has powered the shares to a gain of 130% over the past 12 months and the stock to a $700 billion market cap. ...
2024-03-31 06:15:00 ET 2024 is off to a great start for many investors, with the S&P 500 climbing 10.2% in the first quarter, roughly the performance the index averages for an entire year . Since the end of 2022, the S&P 500 is up a staggering 36.9%, which has some investors...
2024-03-31 02:10:00 ET Summary Eli Lilly and Novo Nordisk have created what Wall Street believes will be the biggest ever pharmaceutical market with its miraculous weight loss drugs. Novo Nordisk's Ozempic and Wegovy, as well as Eli Lilly's Mounjaro and Zepbound, have already gene...
2024-03-29 09:15:00 ET Viking Therapeutics (NASDAQ: VKTX) has emerged this year as a formidable contender in the increasingly popular anti-obesity market. While it doesn't have an approved drug fighting for market share just yet, investors are incredibly bullish on the prospects for...
2024-03-29 09:00:00 ET Relatively small biotechs can see their shares soar -- sometimes significantly -- following positive clinical or regulatory news. That's what has happened this year to Viking Therapeutics (NASDAQ: VKTX) , a mid-cap biotech, with its stock price up by nearl...
2024-03-29 08:51:04 ET Investors are very eager to buy into biotechs and pharmaceuticals that are involved in developing weight-loss medications. This is why Viking Therapeutics (NASDAQ: VKTX) , which has such a drug in its pipeline, has been a popular stock lately. Over the pas...
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
2024-05-18 06:47:00 ET If you go to California's Redwood National Park, you can see the world's tallest tree -- a redwood called Hyperion that's over 380 feet tall. Like every other tree, though, Hyperion started as a small seed. Stocks can be like this, beginning small but growing to a...
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...
2024-05-16 15:15:03 ET Raymond James analyst issues STRONG BUY recommendation for VKTX on May 16, 2024 01:43PM ET. VKTX was trading at $69.81 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy recomm...